ESOC 2025 
Helsinki, May 21- 23rd

In this interview from the 11th European Stroke Organisation Conference (ESOC) in Helsinki, Finland, Cristina Gallego-Fàbrega, member of our team, discusses the complexities of epigenetics in stroke research, highlighting the challenge of distinguishing whether epigenomic changes are a cause or consequence of the disease, and how the emergence of epigenetic drugs is opening new avenues for therapeutic development.

The videos are originally published on the Video Journal of Neurology, but you can also watch them here:

• Targeting the epigenome: epigenetic drugs as a novel approach for stroke treatment

• The potential link between DNA methylation patterns and stroke risk

• Studying epigenetics to develop new treatments for stroke: challenges and advances

*These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

ISGC 29th Boston Workshop
Boston, Oct 12, 13 and 14th

Abstract – PEPSI ICH – BioAge_F-M_v2

ESOC 2023
München, May 24, 25 and 26th.

	Multitrait_analysis_of_intracerebral_hemorrhage_identifies_novel_risk_loci
	Biological_Age_Acceleration_is_Lower_in_Women_with_Hemorragic-Stroke_compared_to_men
	Influence_of_the_gut_microbiome_and_ischaemic_stroke_risk_and_ischaemic_stroke_outcome
	Identification_of_genetic_regulation_at_proteomic_level_in_the_long-term_proteomic_outcome
	Genome-wide_study_reveals_novel sex-specific_loci_associated_with_lacunar_stroke